Mary Baird
Adult Health · Sumter, SCNPI 1578341863
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $6,937 of the $9,605 with a category attached, or 72.2%. 47 manufacturers reported payments, led by Novartis at 25.2% of the total. 2025 is the largest year on record at $5,539, 10.0 times the $555 reported in 2023. Among adult health clinicians in SC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 338 payments — averaging $28.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$2K
- AstraZeneca$677
- Merck$555
- Incyte Corporation$441
- Johnson & Johnson$393
- Daiichi Sankyo Inc.$343
- plus $5K from 41 others
What the payments were for
- Food & beverage$6,93772%
- Education$97210%
- Other$1,69618%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PEMFEXY$137
How this compares
$9,605 in reported general payments places this provider in the 95th percentile of 292 adult health providers in South Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RevlimidLenalidomide | 18 | $362,310 |
| Lenalidomide | 15 | $180,980 |
| EliquisApixaban | 25 | $17,850 |
| XareltoRivaroxaban | 11 | $7,647 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 58 | $1,948 |
| Anastrozole | 66 | $1,271 |
| Oxycodone Hcl | 60 | $1,100 |
| Morphine Sulfate ErMorphine Sulfate | 29 | $1,048 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 48 | $1,035 |
| Tamoxifen Citrate | 22 | $640 |
| Letrozole | 18 | $524 |
| Potassium Chloride | 37 | $407 |
| Ondansetron OdtOndansetron | 17 | $224 |
| Promethazine Hcl | 15 | $126 |
| Acyclovir | 11 | $85 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Bristol Myers SquibbRevlimid | $185 | $362,31018 claims |
| PfizerEliquis | $280 | $17,85025 claims |
| Johnson & JohnsonXarelto | $393 | $7,64711 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 292 adult health providers in South Carolina.
Other adult health in Sumter
- Amy KellySumter$6K
- Karen RobertsonGreenville$69K
- Christine FranzeseTega Cay$30K
- Jessica RiceGreenville$15K
- Michelle PriceCharleston$13K
- Melissa McCarterSpartanburg$12K
- Andrea OlsonWest Columbia$12K
- Jennifer BrittIrmo$11K
- Nichole SnowSpartanburg$10K
- Christi WigginsWest Columbia$10K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.